NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Psoriasis
Date of first enrollment	04/07/2012
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : LY2439821 INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : 80 mg as subcutaneous injection

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	male or female patients aged 20 years or older who have the following: Chronic Ps based on a confirmed diagnosis for at least 6 months prior to baseline (Week 0; Visit 2), a PASI score no less than 12, an sPGA score of no less than 3, and have no less than 10% BSA involvement at both Screening (Visit 1) and baseline (Week 0; Visit 2) Are candidates for phototherapy and/or systemic therapy
Exclude criteria